Synonym
DBM-819; UNII-ZZ64T6XQSM; DBM819; DBM 819;
IUPAC/Chemical Name
1-Propanol, 3-((2,3-dihydro-1-(4-methoxy-2-methylphenyl)-6-methyl-1H-pyrrolo(3,2-C)quinolin-4-yl)amino)-
InChi Key
NQPWMHCSZYMRMV-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H27N3O2/c1-15-6-4-7-18-21(15)25-23(24-11-5-13-27)19-10-12-26(22(18)19)20-9-8-17(28-3)14-16(20)2/h4,6-9,14,27H,5,10-13H2,1-3H3,(H,24,25)
SMILES Code
OCCCNC1=NC2=C(C)C=CC=C2C3=C1CCN3C4=CC=C(OC)C=C4C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
377.49
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kim EJ, Lee MH, Kim SH, Kim SO, Lee DH, Lim HL, Lee HS, Lee MG. Determination of a new reversible proton pump inhibitor, DBM-819, in human plasma and urine, and rat tissue homogenates by high-performance liquid chromatography. J Pharm Biomed Anal. 2002 Oct 15;30(3):511-8. PubMed PMID: 12367675.
2: Choi SJ, Ji HY, Lee HY, Lee DH, Lim H, Lee HS. In vitro metabolism of a new H(+)/K(+) ATPase inhibitor DBM-819 in liver microsomes using HPLC and electrospray mass spectrometry. Biomed Chromatogr. 2001 Dec;15(8):503-6. PubMed PMID: 11748683.
3: Kim EJ, Kim SO, Lee DH, Lim H, Lee MG. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect. Biopharm Drug Dispos. 2001 Apr;22(3):119-28. PubMed PMID: 11745914.
4: Cheon HG, Lee SS, Lim H, Lee DH. Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-. Eur J Pharmacol. 2001 Jan 5;411(1-2):187-192. PubMed PMID: 11137875.
5: Cheon HG, Lim H, Lee DH. Biochemical properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-. Eur J Pharmacol. 2001 Jan 5;411(1-2):181-186. PubMed PMID: 11137874.